Doctor Daniel Gaudet
ECOGENE-21 and Community gene medicine center, clinical lipidology unit, Montreal (Canada)
Membership:
ESC Professional Member
Follow
Biography
Dr. Gaudet is a lipidologist and professor of Medicine at the Université de Montréal (UdeM). He has been and is still principal investigator of several academic studies or clinical trials (PoC and phase 1 to 3) in clinical lipidology. Over the years, he has collaborated to several expert consensus on rare or severe lipid disorders including those of the World Health Organization on FH, the European Atherosclerosis Society and recently those of the National Lipid Association and the American Society of Preventive Cardiology on severe hypertriglyceridemia. He founded and leads ECOGENE-21, a non-profit research organization dedicated to access to innovation for unmet medical needs. Dr. Gaudet is the author of more than 400 scientific publications in peer-reviewed journals and several books and book chapters.
Contributor content
Presentation
Phase 1 trial of a monoclonal antibody targeting the angiopoietin-like protein 3/8 complex in patients with mixed hyperlipidaemia
Presentation
Transition of patients with familial chylomicronaemia syndrome from volanesorsen to olezarsen: safety and pharmacokinetic results
Presentation
Rationale and design of the SHASTA-3 and SHASTA-4 studies: randomized, double-blind, placebo-controlled, phase 3 studies of plozasiran in patients with severe hypertriglyceridemia
Presentation
